Quarterly report pursuant to Section 13 or 15(d)

Reconciliation of IFRS Disclosure to US GAAP Disclosure

v3.21.2
Reconciliation of IFRS Disclosure to US GAAP Disclosure
9 Months Ended
May 31, 2019
Reconciliation Of Ifrs Disclosure To Us Gaap Disclosure [Abstract]  
RECONCILIATION OF IFRS DISCLOSURE TO US GAAP DISCLOSURE
26. RECONCILIATION OF IFRS DISCLOSURE TO US GAAP DISCLOSURE

The Company’s primary listing is on the Toronto Ventures Exchange (“TSXV”). The unaudited condensed consolidated financial statements filed on that exchange are prepared in terms of International Financial Reporting Standards (“IFRS”).


The Company’s unaudited condensed consolidated financial statements on this Form 10-Q is prepared in terms of US GAAP.


The main differences between IFRS and US GAAP are as follows:


For the three months ended   May 31,
2019
    May 31,
2018
 
             
Net loss and comprehensive loss in accordance with IFRS   $ 4,792,890     $ 3,178,839  
                 
Share-based compensation     (248,912 )     -  
Debt issue costs     (43,799 )     -  
                 
Net loss and comprehensive loss in accordance with US GAAP   $ 4,500,179     $ 3,178,839  

For the nine months ended   May 31,
2019
    May 31,
2018
 
             
Net loss and comprehensive loss in accordance with IFRS   $ 13,747,997     $ 8,557,082  
                 
Share-based compensation     (746,736 )     -  
Debt issue costs     51,894       -  
                 
Net loss and comprehensive loss in accordance with US GAAP   $ 13,053,155     $ 8,557,082  

    May 31,
2019
    August 31,
2018
 
             
Total shareholders’ equity in accordance with IFRS   $ 46,193,400     $ 32,929,400  
                 
Components of share capital in accordance with IFRS                
Share capital     100,109,913       77,870,606  
Shares to be issued     1,068,000       996,401  
Share option reserve     14,485,974       12,823,000  
Share warrant reserve     6,246,032       3,207,915  
      121,909,919       94,897,922  
Adjustment for:                
Share-based compensation     (217,862 )     528,874  

Total share capital in accordance with US GAAP

    121,692,057       95,426,796  
                 

Accumulated deficit in accordance with IFRS

    (75,716,519 )     (61,968,522 )
Adjustment for:                
Share-based compensation     217,862       -  
Debt issue costs     (51,894 )     (528,874
Accumulated deficit in accordance with US GAAP     (75,550,551 )     (62,497,396 )
                 
Shareholders equity in accordance with US GAAP   $ 46,141,506     $ 32,929,400  

Share-based compensation


The Company granted certain directors, officers and consultants of the Company share purchase options with vesting terms attached thereto, 25% vested immediately and a further 25%, per annum will vest on the grant date of the share purchase options. These share purchase options were valued using a Black Scholes valuation model utilizing the assumptions as disclosed in note 16 above.


Under IFRS share-based compensation paid to certain directors, consultants and employees were amortized over the vesting period of the option grant using a weighted average expense over the vesting period, including the immediately vesting share purchase options.


Under US GAAP, the share purchase options issued to consultants were expensed immediately and the share purchase options issued to directors and officers were amortized as follows; (i) the value of the twenty five percent of the options that vested immediately were expensed immediately; (ii) the remaining value of the seventy five percent of the options which vest equally on an annual basis are being expensed over the vesting period on a straight line basis.


The difference in treatment between IFRS and US GAAP gave rise to a reversal of expense of $248,912 and $746,736 for the three months and nine months ended May 31, 2019, respectively. There was no impact on the prior periods as all options issued during that period vested immediately and were accordingly expensed immediately.


Debt issue costs


The Company settled certain commitment fees and finders fees related to the issue of convertible notes by the issue of common shares valued at $1,276,980. Under IFRS, these debt issue costs were originally expensed in the three month period ended November 30, 2018 and subsequently recorded as a prepaid commitment fee in the nine month period ended May 31, 2019. Under IFRS this commitment fee is not directly linked to the convertible debt and is amortized on a straight-line basis over the commitment period.


In terms of US GAAP, the commitment fee and finder’s fee is regarded as directly related to the debt and is recorded as a debt discount which is amortized over the life of the debt, including any accelerated amortization due to repayment or early settlement of the debt.


The difference in treatment between IFRS and US GAAP gave rise to a reversal of the prepaid commitment fee of $1,276,980 and the subsequent amortization thereof of $894,587 and the raising of additional debt discount of $1,276,980 and the amortization thereof of $946,481. The difference between the amortization of the prepaid commitment fee and the debt discount amortization to the statement of loss and comprehensive loss was a credit of $43,799 and a charge of $51,894 for the three months and nine months ended May 31, 2019, respectively.